Clinical science and molecular medicine. Supplement最新文献_第6页

Plasma noradrenaline, age and blood pressure: a population study. 血浆去甲肾上腺素、年龄和血压:一项人口研究。

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055073s

D H Jones, C A Hamilton, J L Reid

引用次数: 45

Relation of plasma noradrenaline to blood pressure, age, sex and sodium balance in patients with stable essential hypertension and in normotensive subjects. 血浆去甲肾上腺素与稳定期高血压患者及正常血压者血压、年龄、性别及钠平衡的关系

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055081s

H M Brecht, W Schoeppe

引用次数: 36

The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension. 肾内血管活性物质在原发性高血压发病中的作用。

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055363s

K Abe, M Yasujima, N Irokawa, M Seino, S Chiba, Y Sakurai, M Sato, Y Imai, K Saito, T Ito, T Haruyama, Y Otsuka, K Yoshinaga

引用次数: 19

Biochemical correlates of the increase in blood pressure with age. 血压升高与年龄的生化关系。

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055377s

C E Grim, M H Weinberger, D P Henry, F C Luft, N S Fineberg

引用次数: 8

Blood pressure circadian rhythm in essential hypertension. 原发性高血压患者的血压昼夜节律。

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055391s

M W Millar Craig, S Mann, V Balasubramanian, E B Raftery

引用次数: 43

Effects of labetalol on systemic and pulmonary haemodynamics at rest and during exercise in hypertensive patients. 拉贝他洛尔对高血压患者静息和运动时全身和肺血流动力学的影响。

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055279s

R Fagard, A Amery, T Reybrouck, P Lijnen, L Billiet

引用次数: 3

Effect of selective and non-selective beta-adrenoreceptor blockade on calf blood flow in hypertensive patients. 选择性和非选择性β -肾上腺素受体阻断对高血压患者小腿血流的影响。

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055287s

D L Clement

引用次数: 2

Effects of enkephalins on arterial blood pressure are reduced by propranolol. 心得安可降低脑啡肽对动脉血压的影响。

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055237s

W Simon, K Schaz, U Ganten, G Stock, K H Schlör, D Ganten

{"title":"Effects of enkephalins on arterial blood pressure are reduced by propranolol.","authors":"W Simon, K Schaz, U Ganten, G Stock, K H Schlör, D Ganten","doi":"10.1042/cs055237s","DOIUrl":"https://doi.org/10.1042/cs055237s","url":null,"abstract":"1. The cardiovascular effects of enkephalins have been tested in normotensive Wistar-Kyoto rats. Methionine-enkephalin and leucine-enkephalin increased blood pressure and heart rate after infusion into the brain ventricles. 2. After intravenous injection, blood pressure was increased by methionine-enkephalin and leucine-enkephalin, but heart rate was increased by methionine-enkephalin only. 3. Propranolol treatment reduced the increases in blood pressure following intraventricular methionine-enkephalin and leucine-enkephalin, while only the methionine-enkephalin-induced increases in heart rate were reduced by propranolol. 4. Heart rate and blood pressure responses after intravenous administration of methionine-enkephalins and leucine-enkephalin were not affected by propranolol. 5. Since opioid peptides occur in the blood and in regions of the brain involved in blood pressure regulation, the demonstrated cardiovascular effects to intraventricular and intravenous enkephalins support a role of these peptides in central and peripheral mechanisms of blood pressure control.","PeriodicalId":10672,"journal":{"name":"Clinical science and molecular medicine. Supplement","volume":"4 ","pages":"237s-241s"},"PeriodicalIF":0.0,"publicationDate":"1978-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1042/cs055237s","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11496275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 54

Hypertension and brain catecholamine distribution in the Hebrew University Sabra, H and N rats. 希伯来大学Sabra、H和N大鼠高血压与脑儿茶酚胺分布的关系。

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055105s

N Zamir, Y Gutman, D Ben-Ishay

引用次数: 12

Is high-molecular-weight-renin binding of renin to the protease inhibitors and lipoproteins? 高分子量肾素是否与蛋白酶抑制剂和脂蛋白结合?

Clinical science and molecular medicine. Supplement Pub Date : 1978-12-01 DOI: 10.1042/cs055125s

K Poulsen, A H Nielsen, S Lykkegaard, C Malling, J Krøll, J Jensenius

{"title":"Is high-molecular-weight-renin binding of renin to the protease inhibitors and lipoproteins?","authors":"K Poulsen, A H Nielsen, S Lykkegaard, C Malling, J Krøll, J Jensenius","doi":"10.1042/cs055125s","DOIUrl":"https://doi.org/10.1042/cs055125s","url":null,"abstract":"1. Two high-molecular-weight forms of renin (molecular weights 800 000 and 70 000) are present in mouse plasma. 2. The 800 000 form could be activated and converted into the fully active 40 000 form, by acid or limited proteolysis. The 70 000 form was activated without change in molecular weight. 3. In addition to its enzymic activity, renin was measured by a direct radioimmunoassay, which revealed that the current acid treatment of plasma did not activate all the renin present. 4. Renin is stored as fully active 40 000 renin, with a specific enzymic reactivity of 0.4 times 10(-3) GU ng(-1), in the submaxillary gland of mice. 5. Pure 125I-labelled 40 000 submaxillary renin did not bind to plasma proteins. However, by changing the tertiary structure of renin, it was bound to some of the plasma protease inhibitors; alpha2-macroglobulin, inter-alpha-trypsin inhibitor and alpha2-antithrombin. It was also bound to alpha1- and beta1-lipoprotein, albumin and an unidentified plasma protein. No binding was seen to more than 50 other studied plasma proteins.","PeriodicalId":10672,"journal":{"name":"Clinical science and molecular medicine. Supplement","volume":"4 ","pages":"125s-128s"},"PeriodicalIF":0.0,"publicationDate":"1978-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1042/cs055125s","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11496642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4